Pharma engagement with HCPs and patients during and after the COVID-19 crisis
Wednesday 3rd June
Industry and agency experts attended the PM Society’s webinar on the 3rd June to discuss how Industry engagement will be redefined and shaped by the COVID-19 pandemic.
The webinar was introduced by Carwyn Jones, PM Society Director and Chief Commercial Officer at OPEN Health. He began by explaining that the pharma industry faces significant environmentally-driven transformations to its commercial operating model as a consequence of the COVID-19 crisis. As we begin to emerge from the grip of lockdown, the pharma industry must look at understanding how the pandemic has impacted on HCPs and patients in order to re-engage with them.
To read the full report by Grace Revill, emotive click here.
Watch the full webinar recording below.